Zealand Pharma said Thursday a medical congress had “unintentionally and temporarily” published data from a Phase II clinical trial of its Boehringer Ingelheim-partnered liver disease drug survodutide.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,